OVERVIEW

Practical Recommendations in Immuno and Molecular Oncology (PRIMO) 2022 is organized by Practical Recommendations in Immuno and Molecular Oncology (PRIMO) and will be held from Feb 16 - 19, 2022 at Hilton Waikoloa Village, Waikoloa, Hawaii, United States of America.

Target Audience:
This activity has been designed to meet the educational needs of Academic and Community Practitioners, as well as Registered Nurses and Advanced Practice Registered Nurses, Pharmacists and Physician Assistants from all oncology specialties, treating all disease sites involved in the care of patients with cancer.

Educational Objectives:
• Describe the rationale for mechanisms of action for molecular targeted and immunologic therapies used to treat cancer today.
• Summarize recent advances in targeted and immunologic treatment of hematologic malignancies and solid tumors.
• Identify patients who are appropriate candidates for targeted and immunologic therapies.
• Implement strategies from a healthcare team approach to reduce treatment-related toxicities, and optimize patient outcomes.
• Discuss promising targeted and immunologic approaches being tested in late-stage clinical trials.

Additional details will be posted as soon as information is available.

KEY DATES

Event Start Date
16 Feb, 2022
Event Start Date
Event End Date
19 Feb, 2022
Event End Date
Credits
  • 13.5 IPCE
  • 13.5 AMA PRA Category 1 Credits™
  • 13.5 MOC
  • 13.5 Contact Hours
  • 1.3 CEU
  • 13.5 CME
  • TARGET AUDIENCE

    PharmacistOncologyAdvanced Practitioner NursesPhysician Assistants

    SPECIALITIES

    Oncology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationHilton Waikoloa Village
    69-425 Waikoloa Beach Dr

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235